Item 1.01 Entry into a Material Definitive Agreement.
On January 30, 2023, the Company entered into a Binding Letter of Intent to
acquire Prodigy Stem Cell, LLC as a wholly owned subsidiary of the Company.
Item 2.01 Completion of Acquisition or Disposition of Assets.
On March 1, 2023, the Company completed the acquisition of Prodigy Stem Cell,
LLC as a wholly owned subsidiary. Prodigy Stem Cell, LLC is a New Jersey based
company focused on sales, marketing, and consulting for regenerative medicines.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 1, 2023, the Company appointed Peter Caruso as a Director of the
Company. Mr. Caruso has over 20 years of business development experience and is
the Founder of Prodigy Stem Cell, LLC.
1
© Edgar Online, source Glimpses